Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18501-18550 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02891538
Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
EARLY_PHASE1
Active, not recruiting
51 participants
Started: Jan 31, 2017 · Completed: Dec 2, 2025
1 condition
1 sponsor
1 location
NCT03285425
Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae
N/A
Active, not recruiting
30 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT02482493
All Polyethylene Versus Metal Backed Tibial Components in Knee Replacement
NA
Active, not recruiting
88 participants
Started: Jan 31, 2017 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT03032783
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity
PHASE2
Active, not recruiting
51 participants
Started: Jan 31, 2017 · Completed: Dec 2, 2025
1 condition
1 sponsor
1 location
NCT03305146
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NA
Active, not recruiting
93 participants
Started: Jan 31, 2017 · Completed: Jan 31, 2027
5 conditions
2 sponsors
11 locations
NCT02818920
Neoadjuvant Pembrolizumab
PHASE2
Active, not recruiting
35 participants
Started: Jan 31, 2017 · Completed: Mar 31, 2026
1 condition
2 sponsors
3 locations
NCT03021460
Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
PHASE1
Active, not recruiting
20 participants
Started: Jan 31, 2017 · Completed: Dec 31, 2026
7 conditions
1 sponsor
1 location
NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
PHASE2
Active, not recruiting
818 participants
Started: Jan 30, 2017 · Completed: May 1, 2026
94 conditions
1 sponsor
1011 locations
NCT02782546
Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
PHASE2
Active, not recruiting
60 participants
Started: Jan 30, 2017 · Completed: Sep 16, 2026
1 condition
5 sponsors
1 location
NCT03038568
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
N/A
Active, not recruiting
169 participants
Started: Jan 27, 2017 · Completed: Jan 27, 2026
1 condition
2 sponsors
2 locations
NCT05724212
Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
N/A
Active, not recruiting
220 participants
Started: Jan 27, 2017 · Completed: Feb 1, 2025
1 condition
1 sponsor
1 location
NCT04125914
Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families
NA
Active, not recruiting
384 participants
Started: Jan 26, 2017 · Completed: Apr 30, 2026
3 conditions
2 sponsors
1 location
NCT02971748
Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
PHASE2
Active, not recruiting
37 participants
Started: Jan 26, 2017 · Completed: Dec 31, 2025
5 conditions
2 sponsors
1 location
NCT03053310
Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer
N/A
Active, not recruiting
94 participants
Started: Jan 25, 2017 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT03200834
Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)
NA
Active, not recruiting
239 participants
Started: Jan 25, 2017 · Completed: Jan 3, 2029
1 condition
3 sponsors
1 location
NCT02810743
Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer
PHASE3
Active, not recruiting
174 participants
Started: Jan 25, 2017 · Completed: Dec 1, 2033
1 condition
1 sponsor
11 locations
NCT03033914
A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
PHASE1/PHASE2
Active, not recruiting
82 participants
Started: Jan 25, 2017 · Completed: Jan 31, 2026
1 condition
4 sponsors
10 locations
NCT03035604
Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants
N/A
Active, not recruiting
180 participants
Started: Jan 24, 2017 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT03033927
Predicting Effective Therapy in Pancreatic Cancer
N/A
Active, not recruiting
74 participants
Started: Jan 24, 2017 · Completed: Jan 24, 2026
2 conditions
1 sponsor
4 locations
NCT02957968
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
PHASE2
Active, not recruiting
46 participants
Started: Jan 24, 2017 · Completed: Mar 31, 2026
13 conditions
3 sponsors
4 locations
NCT03032406
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
PHASE2
Active, not recruiting
53 participants
Started: Jan 23, 2017 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT03565913
Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
PHASE2/PHASE3
Active, not recruiting
269 participants
Started: Jan 22, 2017 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02998385
Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protontherapy)
PHASE3
Active, not recruiting
342 participants
Started: Jan 20, 2017 · Completed: Mar 31, 2030
1 condition
2 sponsors
1 location
NCT02999009
Trident II Tritanium Acetabular Shell Outcomes Study
NA
Active, not recruiting
383 participants
Started: Jan 20, 2017 · Completed: Mar 31, 2031
1 condition
1 sponsor
9 locations
NCT03079921
Adrenergic System in Islet Transplantation
EARLY_PHASE1
Active, not recruiting
11 participants
Started: Jan 20, 2017 · Completed: Dec 31, 2025
4 conditions
3 sponsors
1 location
NCT03030066
Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas
NA
Active, not recruiting
47 participants
Started: Jan 19, 2017 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT02899052
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
PHASE2
Active, not recruiting
120 participants
Started: Jan 19, 2017 · Completed: Jun 30, 2027
1 condition
2 sponsors
32 locations
NCT03729778
Impact of HIV-1 and Aging on Mucosal Vaccine Responses
EARLY_PHASE1
Active, not recruiting
100 participants
Started: Jan 18, 2017 · Completed: Jan 1, 2028
4 conditions
1 sponsor
1 location
NCT02954874
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
PHASE3
Active, not recruiting
1,155 participants
Started: Jan 18, 2017 · Completed: May 31, 2026
6 conditions
1 sponsor
920 locations
NCT03261102
TDM Guided Early Optimization of ADAL in Crohn's Disease
NA
Active, not recruiting
200 participants
Started: Jan 17, 2017 · Completed: Jun 1, 2025
3 conditions
2 sponsors
6 locations
NCT06803615
Noninvasive Mapping Before Surgical Ablation
N/A
Active, not recruiting
51 participants
Started: Jan 13, 2017 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03012321
Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
PHASE2
Active, not recruiting
70 participants
Started: Jan 12, 2017 · Completed: Jan 16, 2027
4 conditions
3 sponsors
18 locations
NCT02942290
A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)
PHASE1
Active, not recruiting
129 participants
Started: Jan 12, 2017 · Completed: Jan 31, 2027
1 condition
2 sponsors
37 locations
NCT03367845
Efficacy of Family Programs for Improving Child and Family Health and Development
NA
Active, not recruiting
1,005 participants
Started: Jan 11, 2017 · Completed: Jun 30, 2026
1 condition
2 sponsors
2 locations
NCT03898297
Imaging mGluR5 and Synaptic Density in Psychiatric Disorders
N/A
Active, not recruiting
120 participants
Started: Jan 11, 2017 · Completed: Apr 30, 2026
3 conditions
3 sponsors
1 location
NCT03042156
Immunotherapy And Palliative Radiotherapy Combined In Patients With Advanced Malignancy
N/A
Active, not recruiting
30 participants
Started: Jan 10, 2017 · Completed: Jun 30, 2027
4 conditions
1 sponsor
1 location
NCT03027440
The Developmental Origins of Suicide Mortality
N/A
Active, not recruiting
52,966 participants
Started: Jan 10, 2017 · Completed: Jul 13, 2026
1 condition
1 sponsor
1 location
NCT03022188
Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma
N/A
Active, not recruiting
100 participants
Started: Jan 10, 2017 · Completed: Dec 31, 2026
1 condition
1 sponsor
22 locations
NCT03665948
Effect of Ketogenic and Carbohydrate Diet in Crossfit
NA
Active, not recruiting
70 participants
Started: Jan 9, 2017 · Completed: Dec 20, 2024
5 conditions
3 sponsors
1 location
NCT02984163
Alberta Cancer Exercise Hybrid Effectiveness-Implementation Study
NA
Active, not recruiting
2,570 participants
Started: Jan 9, 2017 · Completed: Jun 30, 2026
1 condition
5 sponsors
2 locations
NCT03028311
Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer
NA
Active, not recruiting
12 participants
Started: Jan 9, 2017 · Completed: Jan 31, 2027
4 conditions
2 sponsors
1 location
NCT07115836
"Standard Versus Single Loop Bypass After Parietal Gastrectomy: a Randomized Double-blind Study"
NA
Active, not recruiting
63 participants
Started: Jan 6, 2017 · Completed: Jan 6, 2028
2 conditions
2 sponsors
1 location
NCT02933411
Low VW Activity in Adolescent HMB
N/A
Active, not recruiting
120 participants
Started: Jan 5, 2017 · Completed: Nov 30, 2025
1 condition
2 sponsors
12 locations
NCT03017794
Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy
N/A
Active, not recruiting
118 participants
Started: Jan 4, 2017 · Completed: Dec 31, 2027
1 condition
1 sponsor
3 locations
NCT02843035
Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension
PHASE2
Active, not recruiting
12 participants
Started: Jan 4, 2017 · Completed: Oct 30, 2026
2 conditions
1 sponsor
7 locations
NCT03018418
Proton Therapy in Reducing Toxicity in Anal Cancer
PHASE2
Active, not recruiting
14 participants
Started: Jan 4, 2017 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT03424174
Clinical Outcome and Cytokine Expression After TKA
NA
Active, not recruiting
80 participants
Started: Jan 4, 2017 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02148796
Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
PHASE2
Active, not recruiting
822 participants
Started: Jan 3, 2017 · Completed: Dec 31, 2025
2 conditions
1 sponsor
11 locations
NCT03024684
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment
PHASE4
Active, not recruiting
240 participants
Started: Jan 3, 2017 · Completed: Jan 31, 2027
1 condition
8 sponsors
6 locations
NCT03003962
Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
PHASE3
Active, not recruiting
669 participants
Started: Jan 2, 2017 · Completed: Jun 30, 2026
1 condition
1 sponsor
92 locations
Previous
1
More pages
368
369
370
371
372
373
374
More pages
431
Next